[
  {
    "tier": "Tier 1",
    "company": "Lonza",
    "hq_country": "Switzerland",
    "industry": "Pharma & Biotech",
    "revenue": "Approx. $6B",
    "situations": "Resource Constraints, Significant Growth",
    "classification": "Likely, Likely",
    "priority_score": "RC: 5",
    "key_evidence": "MP: 0",
    "sources": "SG: 5",
    "_score_int": 5,
    "_frequency": 10
  },
  {
    "tier": "Tier 1",
    "company": "Givaudan",
    "hq_country": "Switzerland",
    "industry": "Fragrance & Flavor",
    "revenue": "Approx. $7B",
    "situations": "Margin Pressure, Supply Chain Disruption",
    "classification": "Confirmed, Likely",
    "priority_score": "RC: 1",
    "key_evidence": "MP: 7",
    "sources": "SG: 0",
    "_score_int": 1,
    "_frequency": 10
  },
  {
    "tier": "Tier 1",
    "company": "Sika",
    "hq_country": "Switzerland",
    "industry": "Specialty Chemicals",
    "revenue": "Approx. $11B",
    "situations": "Significant Growth, Supply Chain Disruption",
    "classification": "Likely, Unclear",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 6",
    "_score_int": 0,
    "_frequency": 10
  },
  {
    "tier": "Tier 1",
    "company": "Straumann",
    "hq_country": "Switzerland",
    "industry": "MedTech",
    "revenue": "Approx. $2B",
    "situations": "Significant Growth",
    "classification": "Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 6",
    "_score_int": 0,
    "_frequency": 10
  },
  {
    "tier": "Tier 1",
    "company": "Sonova",
    "hq_country": "Switzerland",
    "industry": "MedTech",
    "revenue": "Approx. $4B",
    "situations": "Margin Pressure",
    "classification": "Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 5",
    "sources": "SG: 0",
    "_score_int": 0,
    "_frequency": 10
  }
]